Quirijn de Mast

InstitutionRadboud university medical center
AddressThe
Netherlands
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 15 Covid-19 publications, with a maximum of 3 publications in March 2021
    All Publications
    Bar chart showing 96 publications over 16 distinct years, with a maximum of 10 publications in 2015 and 2016 and 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. van den Heuvel FMA, Vos JL, van Bakel B, Duijnhouwer AL, van Dijk APJ, Dimitriu-Leen AC, Koopmans PC, de Mast Q, van de Veerdonk FL, Bosch FH, van den Borst B, Eijsvogels TMH, van Kimmenade RRJ, Nijveldt R. Comparison between myocardial function assessed by echocardiography during hospitalization for COVID-19 and at 4 months follow-up. Int J Cardiovasc Imaging. 2021 Dec; 37(12):3459-3467. PMID: 34286449.
      Citations:    Fields:    Translation:Humans
    2. Citations: 9     Fields:    Translation:HumansCells
    3. Nijman G, Wientjes M, Ramjith J, Janssen N, Hoogerwerf J, Abbink E, Blaauw M, Dofferhoff T, van Apeldoorn M, Veerman K, de Mast Q, Ten Oever J, Hoefsloot W, Reijers MH, van Crevel R, van de Maat JS. Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysis. PLoS One. 2021; 16(3):e0249231. PMID: 33770140.
      Citations: 3     Fields:    Translation:Humans
    4. Pouw N, van de Maat J, Veerman K, Ten Oever J, Janssen N, Abbink E, Reijers M, de Mast Q, Hoefsloot W, van Crevel R, Slieker K, van Apeldoorn M, Blaauw M, Dofferhoff A, Hoogerwerf J. Clinical characteristics and outcomes of 952 hospitalized COVID-19 patients in The Netherlands: A retrospective cohort study. PLoS One. 2021; 16(3):e0248713. PMID: 33735205.
      Citations: 3     Fields:    Translation:Humans
    5. Westerouen van Meeteren MJ, Van den Heuvel FM, Weijers G, Joosten LA, De Mast Q, Van de Veerdonk FL, Pickkers P, De Nooijer AH, Hoefsloot W, Drenth JP, De Korte CL, Nijveldt R, Netea MG, Tjwa ET. A limited role of cytokine storm and fibrogenesis in COVID-19 related liver injury. J Gastrointestin Liver Dis. 2021 03 13; 30(1):166-168. PMID: 33723544.
      Citations:    Fields:    Translation:Humans
    6. Brüggemann RJ, Moes DJAR, van Rhee KP, van 't Veer NE, Koch BCP, van Rossum M, Windsant-van den Tweel AV, Reijers MHE, van Kimmenade RRJ, Rahamat-Langedoen JC, Rettig TCD, van Raalte R, van Paassen J, Polderman FN, van der Linden PD, Frenzel T, de Mast Q, Burger DM, Schouten J, van de Veerdonk FL, Pickkers P, Ter Heine R. Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals. Int J Antimicrob Agents. 2021 Mar; 57(3):106293. PMID: 33515687.
      Citations:    Fields:    Translation:Humans
    7. Verheijen S, van Luin M, Brüggemann RJ, de Mast Q, Hassing RJ, Burger DM. More gastro-intestinal adverse events in non-ICU hospitalised COVID-19 patients treated with chloroquine versus hydroxychloroquine. Int J Infect Dis. 2021 02; 103:402-403. PMID: 33310106.
      Citations:    Fields:    Translation:Humans
    8. Buijsers B, Yanginlar C, de Nooijer A, Grondman I, Maciej-Hulme ML, Jonkman I, Janssen NAF, Rother N, de Graaf M, Pickkers P, Kox M, Joosten LAB, Nijenhuis T, Netea MG, Hilbrands L, van de Veerdonk FL, Duivenvoorden R, de Mast Q, van der Vlag J. Increased Plasma Heparanase Activity in COVID-19 Patients. Front Immunol. 2020; 11:575047. PMID: 33123154.
      Citations: 28     Fields:    Translation:HumansCellsPHPublic Health
    9. Buijsers B, Yanginlar C, Maciej-Hulme ML, de Mast Q, van der Vlag J. Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients. EBioMedicine. 2020 Sep; 59:102969. PMID: 32853989.
      Citations: 32     Fields:    Translation:HumansCellsPHPublic Health
    10. Citations: 181     Fields:    Translation:HumansCells
    11. Machiels JD, Bleeker-Rovers CP, Ter Heine R, Rahamat-Langendoen J, de Mast Q, Ten Oever J, Bousema T, van Crevel R, Wertheim HF. Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks? Int J Antimicrob Agents. 2020 Jul; 56(1):106056. PMID: 32674929.
      Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
    12. van den Heuvel FMA, Vos JL, Koop Y, van Dijk APJ, Duijnhouwer AL, de Mast Q, van de Veerdonk FL, Bosch F, Kok B, Netea MG, Hoogerwerf J, Hoefsloot W, Tjwa ETTL, de Korte CL, van Kimmenade RRJ, Nijveldt R. Cardiac function in relation to myocardial injury in hospitalised patients with COVID-19. Neth Heart J. 2020 Jul; 28(7-8):410-417. PMID: 32643071.
      Citations: 14     
    13. de Maat S, de Mast Q, Danser AHJ, van de Veerdonk FL, Maas C. Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection. Semin Thromb Hemost. 2020 10; 46(7):835-837. PMID: 32526773.
      Citations: 19     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    14. Dimopoulos G, de Mast Q, Markou N, Theodorakopoulou M, Komnos A, Mouktaroudi M, Netea MG, Spyridopoulos T, Verheggen RJ, Hoogerwerf J, Lachana A, van de Veerdonk FL, Giamarellos-Bourboulis EJ. Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis. Cell Host Microbe. 2020 07 08; 28(1):117-123.e1. PMID: 32411313.
      Citations: 92     Fields:    Translation:HumansCellsPHPublic Health
    15. van de Veerdonk FL, Netea MG, van Deuren M, van der Meer JW, de Mast Q, Brüggemann RJ, van der Hoeven H. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. Elife. 2020 04 27; 9. PMID: 32338605.
      Citations: 113     Fields:    Translation:HumansCellsPHPublic Health
    de Mast's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (254)
    Explore
    _
    Co-Authors (140)
    Explore
    _
    Similar People (60)
    Explore
    _